INS and hepatocellular carcinoma: At the post-receptor level, prolonged treatment with insulin is known to inhibit JAK2/STATs signaling by reducing JAK2 and STAT5 phosphorylation (16) and protein content of STAT3, e.g., in H4IIE hepatoma cells (17).